Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-002336
Filing Date
2025-01-06
Accepted
2025-01-06 17:41:13
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6086
  Complete submission text file 0000950170-25-002336.txt   7410
Mailing Address
Business Address
HICKLIN DANIEL J (Reporting) CIK: 0001260929 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 25512566

Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)